Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Atypical Hemolytic Uremic Syndrome Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Atypical Hemolytic Uremic Syndrome Drugmarket, defines the market attractiveness level of Atypical Hemolytic Uremic Syndrome Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Atypical Hemolytic Uremic Syndrome Drug industry, describes the types of Atypical Hemolytic Uremic Syndrome Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Atypical Hemolytic Uremic Syndrome Drug market and the development prospects and opportunities of Atypical Hemolytic Uremic Syndrome Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Atypical Hemolytic Uremic Syndrome Drug market in Chapter 13.
By Player:
Akari Therapeutics Plc
greenovation Biotech GmbH
Achillion Pharmaceuticals Inc
Alexion Pharmaceuticals Inc
Kedrion SpA
Amgen Inc
Omeros Corp
ChemoCentryx Inc
By Type:
ALN-CC5
CCX-168
ET-006
ETR-001
Mubodina
OMS-72
Others
By End-User:
Clinic
Hospital
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Atypical Hemolytic Uremic Syndrome Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Atypical Hemolytic Uremic Syndrome Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Atypical Hemolytic Uremic Syndrome Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Atypical Hemolytic Uremic Syndrome Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Atypical Hemolytic Uremic Syndrome Drug Market Analysis and Outlook to 2022
-
7.1 Global Atypical Hemolytic Uremic Syndrome Drug Consumption (2017-2022)
-
7.2 United States Atypical Hemolytic Uremic Syndrome Drug Consumption (2017-2022)
-
7.3 Europe Atypical Hemolytic Uremic Syndrome Drug Consumption (2017-2022)
-
7.4 China Atypical Hemolytic Uremic Syndrome Drug Consumption (2017-2022)
-
7.5 Japan Atypical Hemolytic Uremic Syndrome Drug Consumption (2017-2022)
-
7.6 India Atypical Hemolytic Uremic Syndrome Drug Consumption (2017-2022)
-
7.7 South Korea Atypical Hemolytic Uremic Syndrome Drug Consumption (2017-2022)
8 Region and Country-wise Atypical Hemolytic Uremic Syndrome Drug Market Analysis and Outlook to 2028
-
8.1 Global Atypical Hemolytic Uremic Syndrome Drug Consumption Forecast (2022-2028)
-
8.2 United States Atypical Hemolytic Uremic Syndrome Drug Consumption Forecast (2022-2028)
-
8.3 Europe Atypical Hemolytic Uremic Syndrome Drug Consumption Forecast (2022-2028)
-
8.4 China Atypical Hemolytic Uremic Syndrome Drug Consumption Forecast (2022-2028)
-
8.5 Japan Atypical Hemolytic Uremic Syndrome Drug Consumption Forecast (2022-2028)
-
8.6 India Atypical Hemolytic Uremic Syndrome Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Atypical Hemolytic Uremic Syndrome Drug Consumption Forecast (2022-2028)
9 Global Atypical Hemolytic Uremic Syndrome Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Atypical Hemolytic Uremic Syndrome Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global ALN-CC5 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global CCX-168 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global ET-006 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global ETR-001 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Mubodina Consumption and Growth Rate (2017-2022)
-
9.1.6 Global OMS-72 Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Atypical Hemolytic Uremic Syndrome Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Atypical Hemolytic Uremic Syndrome Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Atypical Hemolytic Uremic Syndrome Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global ALN-CC5 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global CCX-168 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global ET-006 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global ETR-001 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Mubodina Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global OMS-72 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Atypical Hemolytic Uremic Syndrome Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Atypical Hemolytic Uremic Syndrome Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Atypical Hemolytic Uremic Syndrome Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Atypical Hemolytic Uremic Syndrome Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Atypical Hemolytic Uremic Syndrome Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Atypical Hemolytic Uremic Syndrome Drug Market Competitive Analysis
-
14.1 Akari Therapeutics Plc
-
14.1.1 Akari Therapeutics Plc Company Details
-
14.1.2 Akari Therapeutics Plc Atypical Hemolytic Uremic Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Akari Therapeutics Plc Atypical Hemolytic Uremic Syndrome Drug Product and Service
-
14.2 greenovation Biotech GmbH
-
14.2.1 greenovation Biotech GmbH Company Details
-
14.2.2 greenovation Biotech GmbH Atypical Hemolytic Uremic Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 greenovation Biotech GmbH Atypical Hemolytic Uremic Syndrome Drug Product and Service
-
14.3 Achillion Pharmaceuticals Inc
-
14.3.1 Achillion Pharmaceuticals Inc Company Details
-
14.3.2 Achillion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Achillion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Product and Service
-
14.4 Alexion Pharmaceuticals Inc
-
14.4.1 Alexion Pharmaceuticals Inc Company Details
-
14.4.2 Alexion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Alexion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Product and Service
-
14.5 Kedrion SpA
-
14.5.1 Kedrion SpA Company Details
-
14.5.2 Kedrion SpA Atypical Hemolytic Uremic Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Kedrion SpA Atypical Hemolytic Uremic Syndrome Drug Product and Service
-
14.6 Amgen Inc
-
14.6.1 Amgen Inc Company Details
-
14.6.2 Amgen Inc Atypical Hemolytic Uremic Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Amgen Inc Atypical Hemolytic Uremic Syndrome Drug Product and Service
-
14.7 Omeros Corp
-
14.7.1 Omeros Corp Company Details
-
14.7.2 Omeros Corp Atypical Hemolytic Uremic Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Omeros Corp Atypical Hemolytic Uremic Syndrome Drug Product and Service
-
14.8 ChemoCentryx Inc
-
14.8.1 ChemoCentryx Inc Company Details
-
14.8.2 ChemoCentryx Inc Atypical Hemolytic Uremic Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 ChemoCentryx Inc Atypical Hemolytic Uremic Syndrome Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Atypical Hemolytic Uremic Syndrome Drug
-
Figure Atypical Hemolytic Uremic Syndrome Drug Picture
-
Table Global Atypical Hemolytic Uremic Syndrome Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Atypical Hemolytic Uremic Syndrome Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Atypical Hemolytic Uremic Syndrome Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Atypical Hemolytic Uremic Syndrome Drug Consumption by Country (2017-2022)
-
Figure United States Atypical Hemolytic Uremic Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Atypical Hemolytic Uremic Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Figure China Atypical Hemolytic Uremic Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Atypical Hemolytic Uremic Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Figure India Atypical Hemolytic Uremic Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Atypical Hemolytic Uremic Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Atypical Hemolytic Uremic Syndrome Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Atypical Hemolytic Uremic Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Atypical Hemolytic Uremic Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Atypical Hemolytic Uremic Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Atypical Hemolytic Uremic Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Atypical Hemolytic Uremic Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Atypical Hemolytic Uremic Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ALN-CC5 Consumption and Growth Rate (2017-2022)
-
Figure Global CCX-168 Consumption and Growth Rate (2017-2022)
-
Figure Global ET-006 Consumption and Growth Rate (2017-2022)
-
Figure Global ETR-001 Consumption and Growth Rate (2017-2022)
-
Figure Global Mubodina Consumption and Growth Rate (2017-2022)
-
Figure Global OMS-72 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global ALN-CC5 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CCX-168 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ET-006 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ETR-001 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mubodina Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global OMS-72 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Atypical Hemolytic Uremic Syndrome Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Atypical Hemolytic Uremic Syndrome Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Akari Therapeutics Plc (Foundation Year, Company Profile and etc.)
-
Table Akari Therapeutics Plc Atypical Hemolytic Uremic Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Akari Therapeutics Plc Atypical Hemolytic Uremic Syndrome Drug Product and Service
-
Table greenovation Biotech GmbH (Foundation Year, Company Profile and etc.)
-
Table greenovation Biotech GmbH Atypical Hemolytic Uremic Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table greenovation Biotech GmbH Atypical Hemolytic Uremic Syndrome Drug Product and Service
-
Table Achillion Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Achillion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Achillion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Product and Service
-
Table Alexion Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Alexion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alexion Pharmaceuticals Inc Atypical Hemolytic Uremic Syndrome Drug Product and Service
-
Table Kedrion SpA (Foundation Year, Company Profile and etc.)
-
Table Kedrion SpA Atypical Hemolytic Uremic Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kedrion SpA Atypical Hemolytic Uremic Syndrome Drug Product and Service
-
Table Amgen Inc (Foundation Year, Company Profile and etc.)
-
Table Amgen Inc Atypical Hemolytic Uremic Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Inc Atypical Hemolytic Uremic Syndrome Drug Product and Service
-
Table Omeros Corp (Foundation Year, Company Profile and etc.)
-
Table Omeros Corp Atypical Hemolytic Uremic Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Omeros Corp Atypical Hemolytic Uremic Syndrome Drug Product and Service
-
Table ChemoCentryx Inc (Foundation Year, Company Profile and etc.)
-
Table ChemoCentryx Inc Atypical Hemolytic Uremic Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table ChemoCentryx Inc Atypical Hemolytic Uremic Syndrome Drug Product and Service
-
